Gamma–aminobutyric acid_A and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle

References

• Laaksonen H, Riekkinen P, Rinne UK, Sonninen V. Brain glutamic acid decarboxylase and gamma-aminobutyric acid in Parkinson's disease. In: Birkmayer W, Hornykiewicz, eds. Advances in Parkinsonism: Biochemistry, Physiology and Treatment, Basel: Editions Roche, 1978: pp. 205–209
   Google Scholar
• Perry TL, Javoy-Agid F, Agid Y, Fibiger HC. Striatal GABAergic neuronal activity is not reduced in Parkinson's disease. J Neuro-chem 1983; 40: 1120–1123
   PubMed Web of Science ®Google Scholar
• Lloyd K, Hornykiewicz O. L-Glutamic acid decarboxylase in Parkinson's disease: Effect of L-DOPA therapy. Nature 1973; 243: 521–523
   PubMed Web of Science ®Google Scholar
• Gaspar P, Javoy-Agid F, Ploaska A, Agid Y. Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brain. JNeurochem 1980; 34: 278–283
   PubMed Web of Science ®Google Scholar
• Sieghart W. Pharmacology of benzodiazepine receptors: An update. J Psychiatr Neurosci 1994; 19: 24–29
   PubMed Web of Science ®Google Scholar
• Mohler H, Richards JG, Wu JY. Autoradiographic localization of benzodiazepine receptors in immunocytochemically identified gamma-aminobutyric synapses. Proc Natl Acad Sci USA 1981; 78: 1935–1938
   PubMed Web of Science ®Google Scholar
• Olsen RW, Tobin AJ. Molecular biology of GABAA receptors. FASEB J 1990; 4: 1469–1480
   PubMed Web of Science ®Google Scholar
• König JFR, Klippel RA. The Rat Brain: A Stereotaxic Atlas of the Forebrain and Ower Parts of the Brain Stem, Baltimore: Williams and Wilkins, 1963
   Google Scholar
• Araki T, Kato H, Kogure K, Kanai Y. Long-term changes in gerbil brain neurotransmitter receptors following transient cerebral ischemia. Br J Pharmacol 1992; 107: 437–442
   PubMed Web of Science ®Google Scholar
• Palac los JM, Walmsley JK, Kuhar MJ. High affinity GABA receptors - autoradiographic localization. Brain Res 1981; 222: 285–307
   PubMed Web of Science ®Google Scholar
• Przedborski 5, Kostie V, Jackson-LewisV, Cadet JL, Burke RE. Effectof unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: A quantitative autoradiographic study. JNeurochem 1991; 57: 1951–1961
   PubMed Web of Science ®Google Scholar
• Araki T, Kato H, Shuto K, Fujiwara T, Itoyama Y. Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography.J Neurol Sci 1997; 148: 131–137
   PubMed Web of Science ®Google Scholar
• Javitch JA, Strittmatter SM, Snyder SH. Differential visualization of dopamine and norepinephrine uptake sites in rat brain using CHImazindol autoradiography. J Neurosci 1985; 5: 1513–1521
   PubMed Web of Science ®Google Scholar
• McGeer PL, Itagaki 5, Akiyama H, McGeer EG. Rate of cell death in parkinson ism indicates active neu ropathologica I process. Ann Neurol 1988; 24: 574–576
   PubMed Web of Science ®Google Scholar
• Fearn ley JM, Lee AJ. Ageing and Parkinson's disease: Substantia nigra regional specificity. Brain 1991; 114: 2283–2301
   PubMed Web of Science ®Google Scholar
• Haefely W, Kyburg E, Genechke M, Mohler H. Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationshipsof their agonists and antagonists. Adv Drug Res 1985; 14: 165–322
   Google Scholar
• Tenn CC, Niles LP. Central-type benzodiazepine receptors mediates the antidopaminergic effect of clonazepam and mela-ton in in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism. JPharmacol Exp Then 1995; 274: 201–206
   PubMedGoogle Scholar
• Haefely W. Benzodiazepine interactions with GABA receptors. Neurosci Lett 1984; 47: 201–206
   PubMed Web of Science ®Google Scholar
• Reisine TD, Nagy JI, Beaumont K, Fibiger HC, Yamamura HI. The localization of receptor binding sites in the substantia nigra and striatum of the rat. Brain Res 1979; 177: 241–252
   PubMed Web of Science ®Google Scholar
• Pan Hs, Penney JB, Young AB. y-Aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-h ydroxydopamine lesions of the medial forebrain bundle. J Neurochem 1985; 45: 1396–1404
   PubMed Web of Science ®Google Scholar
• Churchill L, Dilts RP, Kalivas PW. Autoradiographic localization of y-aminobutyric acidA receptors within the ventral tegmental areas. Neurochem Res 1992; 17: 101–106
   PubMed Web of Science ®Google Scholar
• Cross AJ, Waddington JL.HI-Quinuclidinyl benzylate and[3H]GABA receptor binding in the rat substantia nigra after 6-hydroxydopam ine lesions. Neurosci Lett 1980; 17: 271–275
   PubMed Web of Science ®Google Scholar
• Kupersmith MJ, Lieberman AN. The effect of specific brain lesions on the high affinity binding of GABA in the substantia nigra. Brain Res 1980; 194: 536–539
   PubMed Web of Science ®Google Scholar
• May CH, Guilarte TR, Wagner HN Jr, Vogel S. Intrastriatal infusion of lisuride - a potential treatment for Parkinson's disease? Neurodegeneration 1994; 3: 305–313
   PubMedGoogle Scholar
• Ganalingham KK, Robertson RG. Chronic continuous and inter-mittent 1-3,4-d ihydroxyphen yla la nine treatment differentially af-fect basal ganglia function in 6-hydroxydopamine lesioned rats - an autoradiographic study using F Ffiflunitrazepam. Neuroscience 1993; 57: 673–681
   PubMed Web of Science ®Google Scholar
• Dan'ura T, Kurokawa T, Yamashita A, Yanagiuchi H, Ishibashi S. Inhibition of rat brain adenylatecyclase activity by benzodiazepine through the effects of Gi and catalytic proteins. Life Sci 1988; 42: 469–475
   PubMed Web of Science ®Google Scholar
• Niles LP, Hashemi FS. Pharmacological inhibition of forskolin-stimulated adenylate cyclase activity in rat brain by melatonin, its analogs and diazepam. Biochem Pharmaco11990; 40: 2701-2705
   Google Scholar
• Tenn CC, Neu JM, Niles LP. PK11195 blockade of benzodiaze-pine-induced inhibition of forskolin-stimulated adenylate cyclase activity in the striatum. Br J Pharmaco 11996; 119: 223-228
   Google Scholar
• Ten CC, Niles LP. Sensitization of G protein-coupled benzodiaze-pine receptors in the striatum of 6-hydroxydopamine-lesionedrats. J Neurochem 1997; 69: 1920–1926
   PubMed Web of Science ®Google Scholar
• Araki T, Tanji H, Kato H, Itoyama Y. Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurol Sci 1998; 160: 121–127
   PubMed Web of Science ®Google Scholar